Frazier Life Sciences

public companies
Biotech

Frazier Life Sciences nets $1.1B in long-running biotech fund

Frazier Life Sciences (FLS) has stacked up another sizable biotech-focused capital commitment, netting more than $1.1 billion for its long-running public fund.
Will Maddox Sep 10, 2026 9:44am
dollar sign with colored arrows in a maze

RQ nabs $115M to advance flu prevention antiviral

Jun 24, 2026 9:43am